BioSpace News Archive

SASpine is now offering cutting edge Stem Cell Treatments to patients.

Cerevance, a clinical stage biopharmaceutical company advancing new medicines for brain diseases, today announced the company will present at the BIO CEO & Investor Conference, taking place in New York, Feb. 10 – 11, 2020.

Magellan Health, Inc. (NASDAQ: MGLN) today announced that the Company’s Board of Directors has appointed David Haddock as general counsel and secretary of Magellan Health, effective Monday, February 3, 2020.

Researchers at the National Safety Council and the University of Michigan found that about 1 in 20 adolescents ages 10 to 17 and 1 in 10 young adults ages 18 to 25 report prescription opioid misuse, based on a new review published in Preventive Medicine

Seqirus announced that the U.S. Food and Drug Administration has approved AUDENZ™ Monovalent Vaccine, Adjuvanted) to help protect individuals six months of age and older against influenza A.1 AUDENZ is the first-ever adjuvanted, cell-based influenza vaccine designed to protect against influenza A in the event of a pandemic.

Agathos offers a unique platform for direct physician engagement with performance improvement analytics via mobile-based feedback.

Genesis Biotechnology Group (“GBG”) was subject to a recent malware attack. The attack was limited to the internal research work of a GBG member company engaged in contract research using non-human models to support drug discovery.

Ideal Image MedSpa, the nation’s leading MedSpa specializing in non-surgical aesthetic treatments, launched CoolTone, the latest innovation in body shaping technology.

Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it has obtained a European patent.

CVS Health Corporation will hold a conference call with analysts and investors on Wednesday, February 12, 2020, at 8:00 a.m. to discuss its financial results for the fourth quarter of 2019..